Vitamin D: beyond bone

Abstract

In recent years, vitamin D has been received increased attention due to the resurgence of vitamin D deficiency and rickets in developed countries and the identification of extraskeletal effects of vitamin D, suggesting unexpected benefits of vitamin D in health and disease, beyond bone health. The possibility of extraskeletal effects of vitamin D was first noted with the discovery of the vitamin D receptor (VDR) in tissues and cells that are not involved in maintaining mineral homeostasis and bone health, including skin, placenta, pancreas, breast, prostate and colon cancer cells, and activated T cells. However, the biological significance of the expression of the VDR in different tissues is not fully understood, and the role of vitamin D in extraskeletal health has been a matter of debate. This report summarizes recent research on the roles for vitamin D in cancer, immunity and autoimmune diseases, cardiovascular and respiratory health, pregnancy, obesity, erythropoiesis, diabetes, muscle function, and aging.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 60

1. 1.

   Christakos S, DeLuca HF. Minireview: Vitamin D: is there a role in extraskeletal health? Endocrinology. 2011;152:2930-2936.

   Not in our library10.1210/en.2011-0243

2. 2.

   Dhawan P, Wieder R, Christakos S. CCATT enhancer binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J. Biol. Chem. 2009;284:3086-3095.

   Not in our library10.1074/jbc.m803602200

3. 3.

   Joshi S, Pantalena L-C, Liu XK, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 2011;31:3653-3669.

   Not in our library10.1128/mcb.05020-11

4. 4.

   Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.

   Not in our library10.1126/science.1123933

5. 5.

   Hewison M. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 2011;7:337-345.

   Not in our library10.1038/nrendo.2010.226

6. 6.

   Hewison M, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003;170:5382-5390.

   Not in our library10.4049/jimmunol.170.11.5382

7. 7.

   Jeffery LE, et al. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J. Immunol. 2012;189:5155-5164.

   Not in our library10.4049/jimmunol.1200786

8. 8.

   Gardner DG, Chen S, Glenn DJ, Ni W, Pike DJWFeldman, Adams JS. Vitamin D and the Cardiovascular System. Vitamin D. 2011;541-563.

   Not in our library

9. 9.

   Li YC, Kong J, Wei M, et al. 1,25-dihydroxyvitamin D(3) is a Negative Endocrine Regulator of the Renin-Angiotensin System. J. Clin. Invest. 2002;110:229-238.

   Not in our library10.1172/jci15219

10. 10.

    Chen S, Gardner DG. Liganded Vitamin D Receptor Displays Anti-Hypertrophic Activity in the Murine Heart. J. Steroid. Biochem. Mol. Biol.

    Not in our library10.1016/j.jsbmb.2012.09.007

11. 11.

    Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838-1847.

    Not in our library10.1161/circulationaha.111.032680

12. 12.

    Hollis BW, Johnson D, Hulsey TC, et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone. Miner. 2011;26(10):2341-2357.

    Not in our library10.1002/jbmr.463

13. 13.

    Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy (Cochrane Review). Cochrane Database of Systematic Reviews. 1999.

    Not in our library10.1002/14651858.cd000228

14. 14.

    De-Regil LM, Palacios C, Ansary A, et al. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. 2012;2:CD008873.

    Not in our library10.1002/14651858.cd008873.pub2

15. 15.

    Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue. Int. 2012.

    Not in our library10.1007/s00223-012-9607-4

16. 16.

    Wagner CL, McNeil R, Hamilton SA, et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 2012.

    Not in our library10.1016/j.ajog.2012.10.888

17. 17.

    Wagner CL, Hulsey TC, Fanning D, et al. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006;1:59-70.

    Not in our library10.1089/bfm.2006.1.59

18. 18.

    Wagner CL, Howard C, Hulsey TC, et al. Preliminary Results of a Randomized Controlled Trial of Maternal Supplementation with 6400 IU Vitamin D/day Compared with Maternal & Infant Supplementation of 400 IU/day in Achieving Sufficiency in the Breastfeeding Mother-Infant Dyad. Intl. Society Res. Human Milk Lactation. 2012.

    Not in our library

19. 19.

    Sergeev IN. Novel mediators of vitamin D signaling in cancer and obesity. Immun. Endoc. Metab. Agents Med. Chem. 2009;9:153-158.

    Not in our library

20. 20.

    Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr. Res. Rev. 2012;25:130-141.

    Not in our library10.1017/s0954422412000029

21. 21.

    Sergeev IN. Vitamin D and cellular Ca2+ signaling in breast cancer. Anticancer Res. 2012;32:299-302.

    Not in our library

22. 22.

    Sergeev IN. Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 2005;97:145-151.

    Not in our library10.1016/j.jsbmb.2005.06.007

23. 23.

    Sergeev IN. 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun. 2009;384:18-24.

    Not in our library10.1016/j.bbrc.2009.04.078

24. 24.

    Janssens W, et al. Vitamin D Beyond Bones in COPD: Time to Act. Am. J. Respir Crit. Care Med. 2009.

    Not in our library10.1164/rccm.200810-1576pp

25. 25.

    Janssens W, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 65(3);215-220.

    Not in our library10.1136/thx.2009.120659

26. 26.

    Romme EA, et al. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann. Med. 2012.

    Not in our library10.3109/07853890.2012.671536

27. 27.
    Chronic obstructive pulmonary disease is associated with low levels of vitamin D. · 2012

    Not checked
28. 28.

    Forli L, et al. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J. Intern. Med. 2004;256(1):56-62.

    Not in our library10.1111/j.1365-2796.2004.01337.x

29. 29.

    Hopkinson NS, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 2008;87(2):385-390.

    Not in our library10.1093/ajcn/87.2.385

30. 30.

    Lehouck A, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2012;156(2):105-114.

    Not in our library10.7326/0003-4819-156-2-201201170-00004

31. 31.

    Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792-3798.

    Not in our library10.1378/chest.128.6.3792

32. 32.

    Kumar VA, Kujubu DA, Sim JJ, et al. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J. Nephrol. 2011;24(1):98-105.

    Not in our library10.5301/jn.2010.1830

33. 33.

    Andrews NC. Anemia of inflammation:the cytokine-hepcidin link. J. Clin. Invest. 2004;113(9):1251-1253.

    Not in our library10.1172/jci21441

34. 34.

    Howick J, Glasziou P, Aronson JK. The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute? J. Royal Soc. Med. 2009;102:186-194.

    Not in our library10.1258/jrsm.2009.090020

35. 35.

    Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 2011;65:1005-1015.

    Not in our library10.1038/ejcn.2011.118

36. 36.

    Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxyvitamin D concentration and incident Type 2 Diabetes: A meta-analysis of prospective studies diabetes care.

    Not in our library10.2337/dc12-0962

37. 37.

    Pittas AG, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980-986.

    Not in our library10.2337/dc06-1994

38. 38.
    Study Protocol – Metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: A randomised, placebo-controlled, double-blind vitamin D intervention · 2008

    Not checked
39. 39.

    Mitri J, et al. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 2011;94:486-494.

    Not in our library10.3945/ajcn.111.011684

40. 40.

    Boland R. Role of vitamin D in skeletal muscle function. Endocr. Rev. 1986;7:434-448.

    Not in our library10.1210/edrv-7-4-434

41. 41.

    Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J. Steroid Biochem. Mol. Biol. 2004;89–90:497-501.

    Not in our library10.1016/j.jsbmb.2004.03.059

42. 42.

    Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 2001;33:19-24.

    Not in our library10.1023/a:1017535728844

43. 43.

    Boland R, Feldman D, Glorieux G, Pike W. Vitamin D and Muscle. Vitamin D. 2005;885-898.

    Not in our library

44. 44.

    Boland R. VDR activation of intracellular signaling pathways in skeletal muscle. Mol. Cell. Endocrinol. 2011;34:11-16.

    Not in our library10.1016/j.mce.2011.05.021

45. 45.

    Boland R, Buitrago AR, de Boland C, et al. Non-genomic stimulation of tyrosine phosphorylation cascades by 1,25(OH)2D3 by VDR-dependent and -independent mechanisms in muscle cells. Steroids. 2002;67:477-482.

    Not in our library10.1016/s0039-128x(01)00182-9

46. 46.

    Capiati D, Benassati S, Boland R. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell. Biochem. 2002;86:128-135.

    Not in our library10.1002/jcb.10191

47. 47.

    Houston DK, Neiberg RH, Tooze JA, et al. Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: The health ABC study. J. Gerontol. A Biol. Sci. Med. Sci. 2013;68(2):181-187.

    Not in our library10.1093/gerona/gls136

48. 48.

    Rock CL, Emond JA, Flatt SW, et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity. 2012;20(11):2296-2301.

    Not in our library10.1038/oby.2012.57

49. 49.

    Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study amsterdam. J. Clin. Endocrinol. Metab. 2003;88(12):5766-5772.

    Not in our library10.1210/jc.2003-030604

50. 50.

    Giallauria F, Milaneschi Y, Tanaka T, et al. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 2012;97(10):3717-3723.

    Not in our library10.1210/jc.2012-1584

51. 51.
    Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated Megakaryocytes · 2010

    No notice
52. 52.

    Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu. Rev. Pharmacol. Toxicol. 2011;51:311-336.

    Not in our library10.1146/annurev-pharmtox-010510-100611

53. 53.

    Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 2010;170(13):1135-1141.

    Not in our library10.1001/archinternmed.2010.173

54. 54.

    Milaneschi Y, Shardell M, Corsi AM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J. Clin. Endocrinol. Metab. 2010;95(7):3225-3233.

    Not in our library10.1210/jc.2010-0347

55. 55.

    Dietary reference intakes for calcim and vitamin D. 2011.

    Not in our library

56. 56.

    Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911-1930.

    Not in our library10.1210/jc.2011-0385

57. 57.

    Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001–2006. 2011.

    Not in our library

58. 58.

    Kuchuk NO, Pluijm NM, van Schoor SM, et al. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J. Bone. Min. Res. 2009;24:693-701.

    Not in our library10.1359/jbmr.081209

59. 59.

    Binkley N, Krueger DC, Morgan S, Wiebe D. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin. Chim. Acta. 2010;411:1976-1982.

    Not in our library10.1016/j.cca.2010.08.018

60. 60.

    Christakos S, Dhawan P, Liu Y, et al. New Insights into the mechanisms of vitamin D action. J. Cell. Biochem. 2003;88::695-705.

    Not in our library10.1002/jcb.10423

Cited by papers we hold 6

• Effect of vitamin D3-fortified fruit juice supplementation of 4000 IU daily on the recovery of iron status in childbearing-aged women with marginally low iron stores: Protocol for an 8-week, parallel group, double-blind randomized controlled trial. · 2022
  Not checked
• Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory · 2020
  No notice
• Vitamin D, Autoimmune Disease and Rheumatoid Arthritis · 2019
  No notice
• The Biological Activities of Vitamin D and Its Receptor in Relation to Calcium and Bone Homeostasis, Cancer, Immune and Cardiovascular Systems, Skin Biology, and Oral Health · 2018
  No notice
• Vitamin D and Influenza—Prevention or Therapy? · 2018
  No notice
• Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.